Cerebrovascular Afferent Mechanisms of Migraine
偏头痛的脑血管传入机制
基本信息
- 批准号:7388958
- 负责人:
- 金额:$ 4.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAutomobile DrivingBlood VesselsBradykininCellsCircle of WillisCoculture TechniquesDataDevelopmentDrug Delivery SystemsEventFeedbackFrequenciesFunctional disorderHeadacheHeartHistamineImmunohistochemistryIn VitroInflammationInflammatoryInflammatory ResponseInternal carotid artery structureIon ChannelLabelLocalizedLocationMediator of activation proteinMeningealMeningeal ArteriesMigraineNeurogenic InflammationNeuronsNeuropeptidesNociceptionOther Body PartPainPatternPeripheralPharmaceutical PreparationsPhysiologic pulsePopulationPosterior Horn CellsPropertyProstaglandinsPulse takingRattusSensorySerotonin Receptor 5-HT1DSignal TransductionSiteSpecificitySpinal GangliaStimulusStructureSynaptic TransmissionTestingTherapeuticThinkingTissuesTreatment EfficacyTrigeminal Systemcerebrovascularexcitatory neuronexperiencefollow-upinsightnervous system disorderneuronal cell bodynovelpostsynapticpressurepresynapticreceptorresearch studyresponseserotonin receptorsizevasoconstrictionvoltage clamp
项目摘要
DESCRIPTION (provided by the applicant)
Migraine is a common neurological disorder characterized by severe head pain that is associated with autonomic and sensory dysfunction. Activation of cerebrovascular afferents and resultant neurogenic inflammation are thought to be essential for the development of migraine pain. Evidence suggests that inflammatory mediators such as histamine, bradykinin, and prostaglandin sensitize cerebrovascular afferents. Once sensitized, these afferents may be activated by normally innocuous stimuli, such as heart beat-induced changes in vascular pressure. Activated afferents not only release transmitters that are capable of directly stimulating afferent activity (i.e., feedback-excitation), but that drive an inflammatory response associated with the release of additional mediators that can further activate and sensitize afferent terminals. All of this afferent activity is thought to underlie at least the initiation of the pain experienced during a migraine attack. Administration of triptans is currently one of the most effective treatments for migraine pain. These drugs are serotonin receptor type 1B/1D (5-HT1B/1D) agonists. Although 5-HT1B/1D receptors are ubiquitously expressed in trigeminal and dorsal root ganglion neurons, triptans are not generally antinociceptive, having little efficacy for the treatment of pain arising from other parts of the body. Triptans have been shown to produce vasoconstriction and reduce peripheral neuropeptide expression but neither of these appears to be the primary mechanism of antinociception. Understanding the specificity associated with the anti-nociceptive action of 5-HT1B/1D receptors may provide insight into the mechanisms involved in migraine pain and help identify novel targets for drug treatment. The general hypothesis to be tested in this proposal is that the therapeutic actions of triptans reflect unique response properties of cerebrovascular afferents to inflammatory mediators. This hypothesis will be tested with experiments that examine the distribution of 5-HT1B/1D receptors among afferents innervating the intracranial vasculature and changes in excitability and synaptic transmission of cerebrovascular afferents following inflammation and triptan application. The results from these experiments should help provide unique targets for the treatment of migraine pain and increase the understanding of cerebrovascular afferent mechanisms in initiating migraine pain.
描述(申请人提供)
偏头痛是一种常见的神经系统疾病,其特征是与自主和感觉功能障碍有关的严重头部疼痛。脑血管传入和由此导致的神经源性炎症的激活被认为对于偏头痛疼痛的发展至关重要。有证据表明,炎症介质(例如组胺,心动激肽和前列腺素)使脑血管传入敏感。一旦敏感,这些传入可能会被正常无害的刺激激活,例如心跳引起的血管压力变化。活化的传入不仅释放能够直接刺激传入活动(即反馈激发)的发射机,而且会驱动与释放其他介体有关的炎症反应,这些炎症反应可以进一步激活并敏感传入终端。人们认为所有这些传入的活动至少是偏头痛攻击期间遭受的疼痛的启动。 triptans的给药目前是偏头痛疼痛的最有效治疗方法之一。这些药物是5-羟色胺受体1b/1d(5-HT1B/1D)激动剂。尽管5-HT1B/1D受体在三叉神经和背根神经神经元中普遍表达,但triptans通常并非具有抗伤害感受,对治疗体内其他部位引起的疼痛的疗效很小。曲霉已被证明会产生血管收缩并降低周围神经肽的表达,但它们似乎都不是抗伤害感受的主要机制。了解与5-HT1B/1D受体的抗伤心作用相关的特异性可能会洞悉偏头痛疼痛的机制,并有助于识别用于药物治疗的新靶标。在该提案中要检验的一般假设是,曲普(Triptans)的治疗作用反映了脑血管传入对炎症介体的独特反应特性。该假设将通过实验进行检验,这些实验检查了颅内脉管系统的传入中5-HT1B/1D受体的分布,以及炎症和Triptan应用后脑血管传入的兴奋性和突触传播的变化。这些实验的结果应有助于为偏头痛疼痛的治疗提供独特的目标,并在引发偏头痛疼痛时增加对脑血管传入机制的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea M Harriott其他文献
Andrea M Harriott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea M Harriott', 18)}}的其他基金
Sex differences in the role of gonadal hormones and the hypothalamus in migraine with aura.
性腺激素和下丘脑在先兆偏头痛中作用的性别差异。
- 批准号:
10523716 - 财政年份:2022
- 资助金额:
$ 4.24万 - 项目类别:
Sex Differences in the Role of Gonadal Hormones and the Hypothalamus in Migraine with Aura.
性腺激素和下丘脑在先兆偏头痛中作用的性别差异。
- 批准号:
10650419 - 财政年份:2022
- 资助金额:
$ 4.24万 - 项目类别:
相似国自然基金
基于驾驶人行为理解的人机共驾型智能汽车驾驶权分配机制研究
- 批准号:52302494
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
有条件自动驾驶汽车驾驶人疲劳演化机理与协同调控方法
- 批准号:52372341
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
人机共驾汽车驾驶风险分析及控制权智能交互机理
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
人机共驾汽车驾驶风险分析及控制权智能交互机理
- 批准号:52272413
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
定性与定量分析跟驰行驶中汽车驾驶员情感-行为交互作用机理
- 批准号:71901134
- 批准年份:2019
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Designing a targeted 'super adjuvant' nanoparticle platform for vaccination
设计用于疫苗接种的靶向“超级佐剂”纳米颗粒平台
- 批准号:
10647117 - 财政年份:2023
- 资助金额:
$ 4.24万 - 项目类别:
Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity
药物引起的肝毒性中驱动病理性肝充血的新蛋白水解机制
- 批准号:
10638320 - 财政年份:2023
- 资助金额:
$ 4.24万 - 项目类别:
The microbiota-microglia axis in the regulation of metabolic homeostasis
微生物群-小胶质细胞轴在代谢稳态调节中的作用
- 批准号:
10567163 - 财政年份:2023
- 资助金额:
$ 4.24万 - 项目类别:
Profilin as a Novel Target for Vascular Normalization in Renal Cancer
Profilin 作为肾癌血管正常化的新靶点
- 批准号:
10525305 - 财政年份:2022
- 资助金额:
$ 4.24万 - 项目类别:
Characterization of Biomarkers and the Vascular Amyloid Proteome in a Non-human Primate Model of Alzheimer’s Disease
阿尔茨海默病非人灵长类动物模型中生物标志物和血管淀粉样蛋白组的表征
- 批准号:
10558614 - 财政年份:2022
- 资助金额:
$ 4.24万 - 项目类别: